Ambulatory Neurosurgery Center and UB Neurosurgery Partnered with NOVA Neuro

Announcement

The neuroscience and neurotechnology universities at Buffalo Neurosurgery (UBNS) and ANSC received $144,500 award to launch worldwide’s first-ever multi-omics research initiative focusing on forecasting the ruptureability and risk of intracranial aneurysms (IA) with the help of artificial intelligence. The Nova Neuro, in a strategic partnership with UB neurosurgery, ANSC, has primarily introduced a groundbreaking, accurate multi-comics neuroscience company. The company has recruited a sincere and disciplined team combining molecular data and clinical data with proprietary multimodal models representing high-performance computing.

The model will support elevating predictive modelling that will lead and known to the world's first personalized aneurysm rupture risk assessment tool. Accelerating methodologies hosted and led by global leaders in AI-based neural modeling and precision biology, this project demonstrates a new aspect in brain health prediction. This will be the first grant in the world to embed robust AI to study brain aneurysms by examining or analyzing a vast spectrum of biological data, consisting of proteins, other molecular information, and genes. This partnership has grabbed attention from the investors and the international scientific community for its innovative approach to inspiring neuroscience and AI precision medicine.

The Severity of the Brain Aneurysms

Approximately 6.5 million Americans are affected by an unruptured brain aneurysm. Largely, women are the main target of this condition, and the risk factor triples if a first-degree relative has the same condition. Most of the 50% of cases have witnessed deaths due to brain aneurysm ruptures. No diagnostic tools existed to detect risk using biological data. This project is capable of changing this situation.

Statements From Experts

MD, MBA, FAANS, FACS, Chair of Neurosurgery at UBNS, ANSC Head of Research Co-PI, Elad I. Levy said, “This is not just research, it’s our time to finally answer the question to every family member of aneurysm patients asking whether the patient is at risk.”

MD, FAANS, UBNS attending, co-PI, Rosalind Lai said, “With the help of an AI-powered, data-intensive idea, we hope to uncover the neurogenomics of rupture promptly before it's too late.”

The Missy Project founder, Mary (Executive director of the Missy Project and the mother of Missy) and Enidio Magel, after their 12-year-old daughter, Marisa (Missy) Magel, passed away at summer camp, said, “Missy’s legacy and name breathes on through this project, that holds a potential to protect numerous families from healing the pain. It’s a promise to my daughter and hope for others.”